![]() Cell Matters Cell Matters is a biotechnology company that increases the effectiveness of cell therapy by offering an integrated suite of GMP-compliant services. | ![]() Eleven Tx Eleven Therapeutics is a biotechnology company focused on using ribonucleic acid interference (RNAi) for nucleic acid therapeutics. | ![]() Pluri Biotech Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies. | ![]() EdiGENE EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation). | ||
Founding Date | Founding Date 2017 | Founding Date 2020 | Founding Date 2003 | Founding Date 2022 | Founding Date 2015 |
Type | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Liège, BE HQ | Locations Tel Aviv-Yafo, IL HQ Cambridge, GB Boston, US | Locations Haifa, IL HQ Potsdam, DE | Locations San Mateo, US HQ | Locations Cambridge, US HQ |
Employees | Employees 8 | Employees 29 | Employees 106 | Employees 40 | Employees 49 |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 22m (almost 4 years ago) | Latest funding round N/A | Latest funding round $ 50m (about 3 years ago) | Latest funding round $ 22m (about 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 22m | Total funding raised $ 78.4m | Total funding raised $ 50m | Total funding raised $ 143.5m |

Eleven Therapeutics is a biotechnology company focused on using ribonucleic acid interference (RNAi) for nucleic acid therapeutics.
View company
Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.
View company
EpiBiologics is a company that provides a protein degradation platform.
View company
EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation).
View company